Unresolved Coronary artery aneurysms in an adolescent with multisystemic inflammatory syndrome in children associated with SARS-CoV-2 infection- What happens in the long term?- Case report

Authors

  • Chaitra Govardhan Department of Pediatrics, St. John’s Medical College and Hospital, Bangalore, Karnataka, India
  • Poornima Ragavaiah Naidu Department of Pediatrics, St. John’s Medical College and Hospital, Bangalore, Karnataka, India
  • Fulton D'Souza Department of Pediatrics, St. John’s Medical College and Hospital, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20251892

Keywords:

Coronary artery aneurysm, Case report, Long-term outcome, MIS-C

Abstract

MIS-C, a well-known association with SARS-CoV-2 infection, has been a topic of significant interest. It presents with Kawasaki-like illness along with coronary artery dilation or aneurysms. In this report, we describe a particularly intriguing case of an adolescent with MIS-C presenting with coronary artery aneurysms persisting at the end of a 6-month follow-up, underscoring the importance of this condition. An 11-years-old adolescent female presented with fever, livedoid vasculitis rash over lower limbs, abdominal pain and breathlessness. Diagnosis of MIS-C was established based on the clinical findings, elevated inflammatory markers and positive SARS-CoV-2 IgG antibodies. Echocardiogram evidenced myocardial dysfunction with moderate pericardial effusion and coronary aneurysm. She was treated with intravenous immunoglobulins, steroids and aspirin. Serial follow-up until 6 months showed persisting skin changes and coronary aneurysms with normalized inflammatory markers. MIS-C and its related long-term outcome have been well recognized; however, longer follow-up is not just essential, but urgent in understanding this known yet novel condition.

Metrics

Metrics Loading ...

References

Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143(1):21–32. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.050065

Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y, et al. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American heart association. Circulation. 2024;150(23):481–500. DOI: https://doi.org/10.1161/CIR.0000000000001295

Day-Lewis M, Son MBF, Lo MS. Kawasaki disease: contemporary perspectives. Lancet Child Adolesc Health. 2024;8(10):781–92. DOI: https://doi.org/10.1016/S2352-4642(24)00169-X

Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Available from: https://www.who.int/news. Accessed on 21 January 2025.

Living guidance for clinical management of COVID-1. Available at: www.who.int/publications. Accessed on 21 December 2024.

Wacker J, Malaspinas I, Vallée JP, Beghetti M. Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C). Eur Heart. 2021;42(28):2803. DOI: https://doi.org/10.1093/eurheartj/ehab340

Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory syndrome in a child with covid-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;15;57(7):681–3. DOI: https://doi.org/10.1007/s13312-020-1901-z

Alsaied T, Tremoulet AH, Burns JC, Saidi A, Dionne A, Lang SM, et al. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation. 2021;143(1):78–88. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.049836

Villacis-Nunez DS, Hashemi S, Nelson MC, Flanagan E, Thakral A, Rodriguez F, et al. Giant coronary aneurysms in multisystem inflammatory syndrome in children associated with SARS-CoV-2 Infection. JACC Case Rep. 2021;3(13):1499–508. DOI: https://doi.org/10.1016/j.jaccas.2021.06.043

Arantes Junior MAF, Conegundes AF, Branco Miranda BC, Radicchi Campos ASR, França Vieira AL, Faleiro MD, et al. Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: Systematic review and meta-analysis. Rev Med Virol. 2023;33(3):2432. DOI: https://doi.org/10.1002/rmv.2432

Pal P, Bathia JN, Ganguly M, Gupta P, De H, Singhi AK. Cardiac evaluation in multisystem inflammatory syndrome in children (MIS-C) Associated With COVID-19. Indian Pediatr. 2022;59(4):339–40. DOI: https://doi.org/10.1007/s13312-022-2502-9

Chakraborty A, Johnson JN, Spagnoli J, Amin N, Mccoy M, Swaminathan N, et al. Long-term cardiovascular outcomes of multisystem inflammatory syndrome in children associated with COVID-19 Using an Institution-Based Algorithm. Pediatr Cardiol. 2023;44(2):367–80. DOI: https://doi.org/10.1007/s00246-022-03020-w

Yasuhara J, Masuda K, Watanabe K, Shirasu T, Takagi H, Sumitomo N, et al. Longitudinal cardiac outcomes of multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Cardiol. 2023;44(4):892–907. DOI: https://doi.org/10.1007/s00246-022-03052-2

Downloads

Published

2025-06-25

How to Cite

Govardhan, C., Ragavaiah Naidu, P., & D’Souza, F. (2025). Unresolved Coronary artery aneurysms in an adolescent with multisystemic inflammatory syndrome in children associated with SARS-CoV-2 infection- What happens in the long term?- Case report. International Journal of Contemporary Pediatrics, 12(7), 1269–1272. https://doi.org/10.18203/2349-3291.ijcp20251892

Issue

Section

Case Reports